Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.

Li R, Tang X, Jing Q, Wang Q, Yang M, Han X, Zhao J, Yu X.

Am J Emerg Med. 2017 Nov;35(11):1657-1661. doi: 10.1016/j.ajem.2017.05.024. Epub 2017 May 23.

PMID:
28587952
2.

Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.

Wenmeng W, Qizhu T.

Med Hypotheses. 2011 Feb;76(2):181-3. doi: 10.1016/j.mehy.2010.09.012. Epub 2010 Oct 6.

PMID:
20932648
3.

Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.

Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.

Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):533-40. doi: 10.1097/HJR.0b013e328304feec.

PMID:
18797405
4.

Metabolic therapy for patients with diabetes mellitus and coronary artery disease.

Rosano GM, Vitale C, Fragasso G.

Am J Cardiol. 2006 Sep 4;98(5A):14J-18J. Epub 2006 Jul 24. Review.

PMID:
16931201

Supplemental Content

Loading ...
Support Center